Literature DB >> 19188079

Chest wall resection for lung cancer: indications and techniques.

Erich Stoelben1, Corinna Ludwig.   

Abstract

Lung cancer invasion of the chest wall is not a common challenge and represents only about 5% of all patients resected for lung cancer. In T3N0M0 tumours, long-term survival reaches 40-50%, provided certain conditions are fulfilled. The number of explorative thoracotomies and the rate of non-radical resections might be high due to the local extension of an aggressive tumour. Mortality after resection is as high as for pneumonectomy. For historical and anatomical reasons, we have to divide the patients into two groups: infiltration of, and above, the second rib (Pancoast) and tumours located caudally to the second rib. We have to define the two entities. There is a problem concerning correct diagnosis: many tumours reach the chest wall. If the lung is not adherent to the parietal pleura, a standard lobectomy can be performed. However, in the case of adhesions, the differentiation between tumour invasion and inflammation may be difficult. We do not want to perform over-treatment since lung resection en bloc with the chest wall has a higher morbidity and mortality than lobectomy. But we have to avoid opening the tumour intraoperatively or perform a non-radical resection. Therefore, we need a preoperative diagnostic tool answering the question of extrapulmonary infiltration. In this context, we will discuss whether extrapleural lung resection is acceptable in the case of pleural invasion without chest wall involvement. The prognosis of patients with tumours invading the chest wall and mediastinal lymph node metastasis is worse. But patients with ipsilateral supraclavicular lymph node metastasis are not excluded. Thus, careful clinical investigations are necessary. To achieve complete resection, the surgeon should use anatomical knowledge to choose the best form of access to make radical resection more feasible. The problem of pain after thoracotomy is accentuated after chest wall resection, especially after paravertebral resection. The use of modern pain treatment is very important.

Entities:  

Mesh:

Year:  2009        PMID: 19188079     DOI: 10.1016/j.ejcts.2008.11.032

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  24 in total

1.  Number of Ribs Resected is Associated with Respiratory Complications Following Lobectomy with en bloc Chest Wall Resection.

Authors:  Nicole M Geissen; Robert Medairos; Edgar Davila; Sanjib Basu; William H Warren; Gary W Chmielewski; Michael J Liptay; Andrew T Arndt; Christopher W Seder
Journal:  Lung       Date:  2016-04-23       Impact factor: 2.584

2.  Feasibility of hybrid thoracoscopic lobectomy and en-bloc chest wall resection.

Authors:  Mark F Berry; Mark W Onaitis; Betty C Tong; Stafford S Balderson; David H Harpole; Thomas A D'Amico
Journal:  Eur J Cardiothorac Surg       Date:  2011-12-20       Impact factor: 4.191

3.  [Pulmonary causes of chest pain].

Authors:  B Jany
Journal:  Internist (Berl)       Date:  2017-01       Impact factor: 0.743

4.  Clinical Characteristics of Resected T3 Non-small Cell Lung Cancer Characterized by Parietal Pleural Invasion or Chest Wall Invasion.

Authors:  Takeshi Hanagiri; Shinji Shinohara; Masaru Takenaka; Hidehiko Shimokawa; Yoshika Nagata; Makoto Nakagawa; Hidetaka Uramoto; Tomoko So; Fumihiro Tanaka
Journal:  Indian J Surg       Date:  2012-07-28       Impact factor: 0.656

5.  What is the optimal adjuvant therapy for T3N0 lung cancer invading the chest wall?

Authors:  Makoto Suzuki; Takeshi Mori; Kenji Shiraishi; Koei Ikeda; Yoshiko Masuda; Eri Matsubara; Chika Shirakami; Hironori Hinokuma
Journal:  J Thorac Dis       Date:  2017-11       Impact factor: 2.895

6.  Chest wall resection and reconstruction for lung cancer: surgical techniques and example of integrated multimodality approach.

Authors:  Mauro Loi; Antonio Mazzella; Isacco Desideri; Ludovic Fournel; Emelyne Canny Hamelin; Philippe Icard; Antonio Bobbio; Marco Alifano
Journal:  J Thorac Dis       Date:  2020-01       Impact factor: 2.895

7.  Lidocaine 5 % patches as an effective short-term co-analgesic in cancer pain. Preliminary results.

Authors:  Cristina Garzón-Rodríguez; Miquel Casals Merchan; Agnes Calsina-Berna; Eugenia López-Rómboli; Josep Porta-Sales
Journal:  Support Care Cancer       Date:  2013-09-03       Impact factor: 3.603

8.  A new minimally invasive technique of combined chest wall resection for lung cancer.

Authors:  Takeshi Kawaguchi; Takashi Tojo; Norikazu Kawai; Takashi Watanabe; Motoaki Yasukawa; Shigeki Taniguchi
Journal:  Surg Today       Date:  2016-02-09       Impact factor: 2.549

9.  Variational PET/CT Tumor Co-segmentation Integrated with PET Restoration.

Authors:  Laquan Li; Wei Lu; Shan Tan
Journal:  IEEE Trans Radiat Plasma Med Sci       Date:  2019-04-16

Review 10.  Primary lung tumors invading the chest wall.

Authors:  Pier Luigi Filosso; Alberto Sandri; Francesco Guerrera; Paolo Solidoro; Giulia Bora; Paraskevas Lyberis; Enrico Ruffini; Alberto Oliaro
Journal:  J Thorac Dis       Date:  2016-11       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.